BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yasuma T, Okano Y, Tanaka S, Nishihama K, Eguchi K, Inoue C, Maki K, Uchida A, Uemura M, Suzuki T, D'Alessandro-Gabazza CN, Gabazza EC, Yano Y. Sodium-glucose co-transporter-2 inhibitor-associated euglycemic diabetic ketoacidosis that prompted the diagnosis of fulminant type-1 diabetes: A case report . World J Clin Cases 2021; 9(13): 3163-3169 [PMID: 33969104 DOI: 10.12998/wjcc.v9.i13.3163]
URL: https://www.wjgnet.com/2307-8960/full/v9/i13/3163.htm
Number Citing Articles
1
Empagliflozin/insulinReactions Weekly 2022; 1901(1): 239 doi: 10.1007/s40278-022-12916-1